Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 983 products on this category.

Product data	Purity	Price range	Estimated delivery
Fulvestrant Impurity 8 REF: 4Z-F-3130	- - -	To inquire	Tue 17 Dec 24
Nintedanib Impurity 46 REF: 4Z-N-066064	- - -	To inquire	Tue 17 Dec 24
Enzalutamide Impurity 37 REF: 4Z-E-068050	- - -	To inquire	Tue 17 Dec 24
Lenvatinib Impurity 56 REF: 4Z-L-124063	- - -	To inquire	Tue 17 Dec 24
Olaparib Impurity 51 REF: 4Z-O-032056	- - -	To inquire	Tue 17 Dec 24
Nintedanib Impurity 80 REF: 4Z-N-066091CAS: 262368-25-2	- - -	To inquire	Tue 17 Dec 24
Olaparib Impurity 43 REF: 4Z-O-032048CAS: 42086-73-7	- - -	To inquire	Tue 17 Dec 24
Enzalutamide Impurity 3 REF: 4Z-E-068011	- - -	To inquire	Tue 17 Dec 24
Fulvestrant Impurity 15 REF: 4Z-F-3123	- - -	To inquire	Tue 17 Dec 24
Olaparib Impurity 81 Sodium Salt REF: 4Z-O-032088	- - -	To inquire	Tue 17 Dec 24
Leuprorelin (Leuprolide) Acetate REF: 4Z-PL-4134CAS: 74381-53-6	- - -	To inquire	Tue 17 Dec 24
N-Nitroso Nintedanib REF: 4Z-N-066093	- - -	To inquire	Tue 17 Dec 24
Carfilzomib Impurity 38 REF: 4Z-C-121041	- - -	To inquire	Tue 17 Dec 24
Gimeracil Impurity 20 REF: 4Z-G-047025CAS: 149143-68-0	- - -	To inquire	Tue 17 Dec 24
Lenvatinib Impurity 34 REF: 4Z-L-124040CAS: 417722-79-3	- - -	To inquire	Tue 17 Dec 24
N-Nitroso Olaparib Impurity 33 REF: 4Z-O-032090	- - -	To inquire	Tue 17 Dec 24
N-Nitroso Olaparib Impurity 15 REF: 4Z-O-032089	- - -	To inquire	Tue 17 Dec 24
Carfilzomib Impurity 76 REF: 4Z-C-121079CAS: 868540-16-3	- - -	To inquire	Tue 17 Dec 24
Palbociclib Impurity 57 REF: 4Z-P-196064	- - -	To inquire	Tue 17 Dec 24
Olaparib Impurity 40 REF: 4Z-O-032045CAS: 2268028-68-6	- - -	To inquire	Tue 17 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Fulvestrant Impurity 8

Ref: 4Z-F-3130

Nintedanib Impurity 46

Ref: 4Z-N-066064

Enzalutamide Impurity 37

Ref: 4Z-E-068050

Lenvatinib Impurity 56

Ref: 4Z-L-124063

Olaparib Impurity 51

Ref: 4Z-O-032056

Nintedanib Impurity 80

Ref: 4Z-N-066091

Olaparib Impurity 43

Ref: 4Z-O-032048

Enzalutamide Impurity 3

Ref: 4Z-E-068011

Fulvestrant Impurity 15

Ref: 4Z-F-3123

Olaparib Impurity 81 Sodium Salt

Ref: 4Z-O-032088

Leuprorelin (Leuprolide) Acetate

Ref: 4Z-PL-4134

N-Nitroso Nintedanib

Ref: 4Z-N-066093

Carfilzomib Impurity 38

Ref: 4Z-C-121041

Gimeracil Impurity 20

Ref: 4Z-G-047025

Lenvatinib Impurity 34

Ref: 4Z-L-124040

N-Nitroso Olaparib Impurity 33

Ref: 4Z-O-032090

N-Nitroso Olaparib Impurity 15

Ref: 4Z-O-032089

Carfilzomib Impurity 76

Ref: 4Z-C-121079

Palbociclib Impurity 57

Ref: 4Z-P-196064

Olaparib Impurity 40

Ref: 4Z-O-032045